Garnette D. Draper

Array ( [id] => 4120701 [patent_doc_number] => 06072037 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Antibodies to the IL-17 receptor' [patent_app_type] => 1 [patent_app_number] => 9/022696 [patent_app_country] => US [patent_app_date] => 1998-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18102 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/072/06072037.pdf [firstpage_image] =>[orig_patent_app_number] => 022696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4120640 [patent_doc_number] => 06072033 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Receptor that binds IL-17' [patent_app_type] => 1 [patent_app_number] => 9/022255 [patent_app_country] => US [patent_app_date] => 1998-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18099 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/072/06072033.pdf [firstpage_image] =>[orig_patent_app_number] => 022255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103093 [patent_doc_number] => 06100235 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Methods of treating immune and inflammatory response with IL-17 receptors' [patent_app_type] => 1 [patent_app_number] => 9/022260 [patent_app_country] => US [patent_app_date] => 1998-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18100 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100235.pdf [firstpage_image] =>[orig_patent_app_number] => 022260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4291832 [patent_doc_number] => 06197525 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Assay kits for detection and methods of inhibiting IL-17 binding' [patent_app_type] => 1 [patent_app_number] => 9/022257 [patent_app_country] => US [patent_app_date] => 1998-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10334 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197525.pdf [firstpage_image] =>[orig_patent_app_number] => 022257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359163 [patent_doc_number] => 06191104 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Methods of treating graft rejection with the IL-17 receptor' [patent_app_type] => 1 [patent_app_number] => 9/022259 [patent_app_country] => US [patent_app_date] => 1998-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10349 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191104.pdf [firstpage_image] =>[orig_patent_app_number] => 022259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089297 [patent_doc_number] => 06018029 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'DNA encoding canine interleukin-1 receptor antagonist' [patent_app_type] => 1 [patent_app_number] => 9/000630 [patent_app_country] => US [patent_app_date] => 1997-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 7313 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/018/06018029.pdf [firstpage_image] =>[orig_patent_app_number] => 000630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4174180 [patent_doc_number] => 06083906 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Method of regulating nitric oxide production or arthritis with soluble IL-17 receptor' [patent_app_type] => 1 [patent_app_number] => 8/978773 [patent_app_country] => US [patent_app_date] => 1997-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14597 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083906.pdf [firstpage_image] =>[orig_patent_app_number] => 978773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4306630 [patent_doc_number] => 06187908 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Tubby 2 polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/977865 [patent_app_country] => US [patent_app_date] => 1997-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2619 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187908.pdf [firstpage_image] =>[orig_patent_app_number] => 977865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089711 [patent_doc_number] => 06096300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Treatment of myeloproliferative disease with exodus chemokine' [patent_app_type] => 1 [patent_app_number] => 8/970403 [patent_app_country] => US [patent_app_date] => 1997-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16823 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096300.pdf [firstpage_image] =>[orig_patent_app_number] => 970403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4196274 [patent_doc_number] => 06013476 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'DNA encoding tumor necrosis related receptor TR7' [patent_app_type] => 1 [patent_app_number] => 8/959382 [patent_app_country] => US [patent_app_date] => 1997-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10329 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013476.pdf [firstpage_image] =>[orig_patent_app_number] => 959382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3973774 [patent_doc_number] => 05916767 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'DNA encoding human interleukin-5 receptor' [patent_app_type] => 1 [patent_app_number] => 8/939727 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 17719 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916767.pdf [firstpage_image] =>[orig_patent_app_number] => 939727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3926310 [patent_doc_number] => 05945511 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Class II cytokine receptor' [patent_app_type] => 1 [patent_app_number] => 8/943087 [patent_app_country] => US [patent_app_date] => 1997-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57414 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945511.pdf [firstpage_image] =>[orig_patent_app_number] => 943087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3923106 [patent_doc_number] => 05945310 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'DNA encoding members of the IL-1 family, IL-1 delta' [patent_app_type] => 1 [patent_app_number] => 8/939300 [patent_app_country] => US [patent_app_date] => 1997-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10461 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945310.pdf [firstpage_image] =>[orig_patent_app_number] => 939300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4138875 [patent_doc_number] => 06015883 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Rantes homolog from prostate' [patent_app_type] => 1 [patent_app_number] => 8/936772 [patent_app_country] => US [patent_app_date] => 1997-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16132 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015883.pdf [firstpage_image] =>[orig_patent_app_number] => 936772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940173 [patent_doc_number] => 05989867 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'DNA encoding IL-10-like homologue; related reagents' [patent_app_type] => 1 [patent_app_number] => 8/934959 [patent_app_country] => US [patent_app_date] => 1997-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16715 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989867.pdf [firstpage_image] =>[orig_patent_app_number] => 934959 [rel_patent_id] =>[rel_patent_doc_number] =>)